Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2025-12-31 @ 3:06 AM
Study NCT ID:
NCT01067833
Status:
TERMINATED
Last Update Posted:
2011-05-16
First Post:
2010-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Oral K201 for Prevention of AF Recurrence
Sponsor:
Sequel Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-12
Completion Date Type:
ESTIMATED
First Submit Date:
2010-02-10
First Submit QC Date:
None
Study First Post Date:
2010-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-13
Last Update Post Date:
2011-05-16
Last Update Post Date Type:
ESTIMATED